Illuminating the molecular basis of diabetic arteriopathy: A proteomic comparison of aortic tissue from diabetic and healthy rats

Proteomics

Volumn 10, Issue 18, 2010, Pages 3367-3378

  Jüllig, Mia ^a,b   Chen, Xiuyin ^a   Middleditch, Martin J ^a,b   Vazhoor, Greeshma ^a   Hickey, Anthony J ^a   Gong, Deming ^a   Lu, Jun ^a,c   Zhang, Shaoping ^a,b   Phillips, Anthony R J ^a,b,d   Cooper, Garth J S ^a,b,e,f  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aorta; Arterial mitochondria; Arterial remodelling; Biomedicine; Diabetic arteriopathy; Streptozotocin diabetic rat

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ELECTRON TRANSPORT; GLYCOLYSIS; MALE; MICROFILAMENT; MITOCHONDRION; MUSCLE FIBRIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RAT; WESTERN BLOTTING;

ANIMALS; AORTA; AORTIC DISEASES; DIABETES COMPLICATIONS; MALE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 77956528210     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000276     Document Type: Article

References (54)

1. Nathan, D. M., Lachin, J., Cleary, P., Orchard, T. et al., Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 2003, 348, 2294-2303.
2. Selvin, E., Najjar, S. S., Cornish, T. C., Halushka, M. K., A comprehensive histopathological evaluation of vascular medial fibrosis: insights into the pathophysiology of arterial stiffening. Atherosclerosis 2010, 208, 69-74.
3. Cruickshank, K., Riste, L., Anderson, S. G., Wright, J. S. et al., Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002, 106, 2085-2090. (Pubitemid 35192814)
4. Nakashima, Y., Fujii, H., Sumiyoshi, S., Wight, T. N., Sueishi, K., Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1159-1165.
5. Mahfouz Badran, H., Elnoamany, M., Impact of type 2 diabetes mellitus on aortic elastic properties in normotensive diabetes: Doppler tissue imaging study. J. Am. Soc. Echocardiogr. 2006, 19, 1471-1481.
6. Fukuda, G., Khan, Z. A., Barbin, Y. P., Farhangkhoee, H. et al., Endothelin-mediated remodeling in aortas of diabetic rats. Diabetes Metab. Res. Rev. 2005, 21, 367-375.
7. Gong, D., Lu, J., Chen, X., Choong, S. Y. et al., Molecular changes evoked by triethylenetetramine treatment in the extracellular matrix of the heart and aorta in diabetic rats. Mol. Pharmacol. 2006, 70, 2045-2051.
8. Movat, H. Z., Demonstration of all connective tissue elements in a single section. AMA Arch. Pathol. 1955, 55, 289-295.
9. Jüllig, M., Hickey, A. J., Middleditch, M. J., Crossman, D. J. et al., Characterization of proteomic changes in cardiac mitochondria in streptozotocin-diabetic rats using iTRAQ™ isobaric tags. Proteomics Clin. Appl. 2007, 1, 565-576.
10. Jüllig, M., Hickey, A. J., Chai, C. C., Skea, G. L. et al., Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics 2008, 8, 2556-2572.
11. Brion, L. P., Schwartz, J. H., Zavilowitz, B. J., Schwartz, G. J., Micro-method for the measurement of carbonic anhydrase activity in cellular homogenates. Anal. Biochem. 1988, 175, 289-297.
12. Ochiai, Y., Itoh, K., Sakurai, E., Tanaka, Y., Molecular cloning and characterization of rat semicarbazide-sensitive amine oxidase. Biol. Pharm. Bull. 2005, 28, 413-418. (Pubitemid 40879960)
13. Lu, Y. L., Hu, S. J., Shen, Z. J., Shao, Y. C., Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats. Chin. Med. J. (Engl.) 2004, 117, 1165-1169.
14. Mayr, M., Mayr, U., Chung, Y. L., Yin, X. et al., Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 2004, 4, 3751-3761.
15. Cho, W. C., Yip, T. T., Chung, W. S., Leung, A. W. et al., Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. J. Cell. Biochem. 2006, 99, 256-268.
16. Victor, V. M., Rocha, M., Sola, E., Banuls, C. et al., Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Des. 2009, 15, 2988-3002.
17. Gamble, W., Atherosclerosis: the carbonic anhydrase, carbon dioxide, calcium concerted theory. J. Theor. Biol. 2006, 239, 16-21.
18. Almofti, M. R., Huang, Z., Yang, P., Rui, Y., Proteomic analysis of rat aorta during atherosclerosis induced by high cholesterol diet and injection of vitamin D3. Clin. Exp. Pharmacol. Physiol. 2006, 33, 305-309.
19. Panayiotou, A., Griffin, M., Georgiou, N., Bond, D. et al., ApoB/ApoA1 ratio and subclinical atherosclerosis. Int. Angiol. 2008, 27, 74-80.
20. Wakabayashi, I., Masuda, H., Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus. Clin. Chim. Acta 2006, 373, 127-131. (Pubitemid 44292186)
21. Gunczler, P., Lanes, R., Soros, A., Verdu, L. et al., Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes. J. Pediatr. 2006, 149, 320-323. (Pubitemid 44291375)
22. Rao, P. V., Lu, X., Standley, M., Pattee, P. et al., Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007, 30, 629-637.
23. Murphy, M. P., How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1-13.
24. Giugliano, D., Ceriello, A., Paolisso, G., Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19, 257-267.
25. Liao, M., Liu, Z., Bao, J., Zhao, Z. et al., A proteomic study of the aortic media in human thoracic aortic dissection: implication for oxidative stress. J. Thorac. Cardiovasc. Surg. 2008, 136, 65-72, 72 e61-63.
26. Sethi, A. S., Lees, D. M., Douthwaite, J. A., Dawnay, A. B., Corder, R., Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells. J. Vasc. Res. 2006, 43, 175-183. (Pubitemid 43247999)
27. Boomsma, F., van den Meiracker, A. H., Winkel, S., Aanstoot, H. J. et al., Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis. Diabetologia 1999, 42, 233-237.
28. Garpenstrand, H., Ekblom, J., Backlund, L. B., Oreland, L., Rosenqvist, U., Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet. Med. 1999, 16, 514-521.
29. Gokturk, C., Nilsson, J., Nordquist, J., Kristensson, M. et al., Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am. J. Pathol. 2003, 163, 1921-1928.
30. Raisanen, S. R., Lehenkari, P., Tasanen, M., Rahkila, P. et al., Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J. 1999, 13, 513-522.
31. Branton, M. H., Kopp, J. B., TGF-beta and fibrosis. Microbes Infect. 1999, 1, 1349-1365.
32. Pohlers, D., Brenmoehl, J., Loffler, I., Muller, C. K. et al., TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim. Biophys. Acta 2009, 1792, 746-756.
33. Gilbert, R. E., Rumble, J. R., Cao, Z., Cox, A. J. et al., Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circ. Res. 2000, 86, 158-165. (Pubitemid 30086176)
34. Rumble, J. R., Cooper, M. E., Soulis, T., Cox, A. et al., Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J. Clin. Invest. 1997, 99, 1016-1027.
35. Candido, R., Jandeleit-Dahm, K. A., Cao, Z., Nesteroff, S. P. et al., Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 2002, 106, 246-253.
36. Sun, H., Zhong, M., Miao, Y., Ma, X. et al., Impaired elastic properties of the aorta in fat-fed, streptozotocin-treated rats. Vascular remodeling in diabetic arteries. Cardiology 2009, 114, 107-113.
37. Wicks, J., Haitchi, H. M., Holgate, S. T., Davies, D. E., Powell, R. M., Enhanced upregulation of smooth muscle related transcripts by TGF beta2 in asthmatic (myo) fibroblasts. Thorax 2006, 61, 313-319.
38. Adam, P. J., Regan, C. P., Hautmann, M. B., Owens, G. K., Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J. Biol. Chem. 2000, 275, 37798-37806.
39. Horiuchi, K., Amizuka, N., Takeshita, S., Takamatsu, H. et al., Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 1999, 14, 1239-1249.
40. Levens, E., Luo, X., Ding, L., Williams, R. S., Chegini, N., Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin- releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling. Mol. Hum. Reprod. 2005, 11, 489-494. (Pubitemid 41258235)
41. Lin, D. W., Chang, I. C., Tseng, A., Wu, M. L. et al., Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2. J. Biol. Chem. 2008, 283, 15003-15014.
42. Wang, D., Park, J. S., Chu, J. S., Krakowski, A. et al., Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J. Biol. Chem. 2004, 279, 43725-43734.
43. Ikegawa, S., Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases. Curr. Med. Chem. 2008, 15, 724-728.
44. Desmouliere, A., Gabbiani, G., The cytoskeleton of arterial smooth muscle cells during human and experimental atheromatosis. Kidney Int. Suppl. 1992, 37, S87-S89.
45. Holland, J. A., Goss, R. A., O'Donnell, R. W., Chang, M. M. et al., Low-density lipoprotein induced actin cytoskeleton reorganization in endothelial cells: mechanisms of action. Endothelium 2001, 8, 117-135.
46. Rayner, K., Chen, Y. X., McNulty, M., Simard, T. et al., Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ. Res. 2008, 103, 133-141.
47. McGrath, J. L., Osborn, E. A., Tardy, Y. S., Dewey,C. F., Jr., Hartwig, J. H., Regulation of the actin cycle in vivo by actin filament severing. Proc. Natl. Acad. Sci. USA 2000, 97, 6532-6537.
48. Moriyama, K., Yahara, I., Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover. J. Cell Sci. 2002, 115, 1591-1601. (Pubitemid 34520589)
49. Ji, L., Chauhan, A., Chauhan, V., Upregulation of cytoplasmic gelsolin, an amyloid-beta-binding protein, under oxidative stress conditions: involvement of protein kinase C. J. Alzheimers Dis. 2009, 19, 829-838.
50. Winder, S. J., Walsh, M. P., Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J. Biol. Chem. 1990, 265, 10148-10155.
51. Lange, K., Gartzke, J., A critical comparison of the current view of Ca signaling with the novel concept of F-actin-based Ca signaling. Crit. Rev. Eukaryot. Gene Expr. 2006, 16, 307-365. (Pubitemid 46269177)
52. O'Rourke, M. F., Arterial aging: pathophysiological principles. Vasc. Med. 2007, 12, 329-341.
53. Cooper, G. J., Young, A. A., Gamble, G. D., Occleshaw, C. J. et al., A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia 2009, 52, 715-722.
54. Gong, D., Chen, X., Middleditch, M., Huang, L. et al., Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats. Proteomics 2009, 9, 4309-4320.